July 13, 2018

Mayo Clinic Researcher Cites Positive Results for Cologuard-Style Liver Cancer Test

By Kelley Luckstein

Twin Cities Business
by Don Jacobson

A prominent Mayo Clinic gastroenterologist who co-invented the Cologuard stool test for colorectal cancer now says he and his colleagues at Exact Sciences Corp. have also developed a highly accurate Twin Cities Business Magazine Logoblood DNA test for detecting liver cancer. Dr. John Kisiel, a consultant in Mayo’s gastroenterology and hepatology division and an assistant medical school professor, originally co-developed the cancer-detection method used in Cologuard, which was licensed to Madison, Wisconsin-based Exact Sciences under a 2009 scientific collaboration and venture capital investment.

Reach: Twin Cities Business is a monthly business magazine with a circulation of more than 30,000 and more than 74,000 readers. Its website has more than 45,000 unique visitors each month. The magazine also posts daily business news on its website.

Context: Speaking at the 2018 Digestive Disease Week conference, the world’s largest gathering of gastroenterologists and scientists in the field, Kisiel laid out the results of a novel panel of six DNA biomarkers in detecting hepatocellular carcinoma (HCC), the most common type of liver cancer.

Contact: Joe Dangor

Tags: Cologuard stool test, Dr. John Kisiel, Twin Cities Business, Uncategorized

Contact Us · Privacy Policy